NEW YORK (GenomeWeb News) — Helicos BioSciences has begun manufacturing its Heliscope genome sequencer at its facility in Cambridge, Mass., the company said this week.
The company also said it is “approach[ing] receipt of our first commercial order.” It did not elaborate.
The company, which began trading on the Nasdaq exchange late last month, said it is expecting to launch the Heliscope late this year.